{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:06:23Z","timestamp":1790683583150,"version":"4.1.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012779","name":"R\u00e9seau Qu\u00e9b\u00e9cois de Recherche sur les M\u00e9dicaments","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The scientific and medical community faced an unprecedented global health hazard that led to nearly 7 million deaths attributable to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In spite of the development of efficient vaccines against SARS-CoV-2, many people remain at risk of developing severe symptoms as the virus continues to spread without beneficial patient therapy. The hyper-inflammatory response to SARS-CoV-2 infection progressing to acute respiratory distress syndrome remains an unmet medical need for improving patient care. The viral infection stimulates alveolar macrophages to adopt an inflammatory phenotype regulated, at least in part, by the cluster of differentiation 36 receptor (CD36) to produce unrestrained inflammatory cytokine secretions. We suggest herein that the modulation of the macrophage response using the synthetic CD36 ligand hexarelin offers potential as therapy for halting respiratory failure in SARS-CoV-2-infected patients.<\/jats:p>","DOI":"10.3389\/fphar.2024.1303342","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T04:42:19Z","timestamp":1707280939000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator"],"prefix":"10.3389","volume":"15","author":[{"given":"Jade","family":"Gauvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dubuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"L\u00ea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela","family":"Tugores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Flamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Flamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Lubell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Marleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0140-6736(22)01109-6","article-title":"Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis","volume":"400","author":"Abani","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"crossref","first-page":"A1284","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A1284","article-title":"Soluble cluster of differentiation 36 (sCD36) as a biomarker for outcomes in coronavirus disease (COVID-19) acute respiratory distress syndrome (ARDS)","volume-title":"A33. BIOMARKERS, allergy and immune responses in COVID-19","author":"Alghanim","year":"2022"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.biocel.2008.11.002","article-title":"Oxidized phospholipids: biomarker for cardiovascular diseases","volume":"41","author":"Ashraf","year":"2009","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/ijms19061801","article-title":"Role of human macrophage polarization in inflammation during infectious diseases","volume":"19","author":"Atri","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12939-022-01729-x","article-title":"Inequality in the distribution of Covid-19 vaccine: a systematic review","volume":"21","author":"Bayati","year":"2022","journal-title":"Int. J. Equity Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1080\/07853890.2022.2133162","article-title":"COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients","volume":"54","author":"Bellino","year":"2022","journal-title":"Ann. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/cvr\/cvs225","article-title":"EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice","volume":"96","author":"Bessi","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/bf03343555","article-title":"Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans","volume":"22","author":"Bisi","year":"1999","journal-title":"J. Endocrinol. Investig."},{"key":"B9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/01.RES.0000016164.02525.B4","article-title":"CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart","volume":"90","author":"Bodart","year":"2002","journal-title":"Circ. Res."},{"key":"B10","volume-title":"COVID-19 treatments [Online]","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/psb.1979","article-title":"Paxlovid: antiviral combination for the treatment of COVID-19","volume":"33","author":"Chaplin","year":"2022","journal-title":"Prescriber"},{"key":"B12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jpha.2022.10.005","article-title":"Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection","volume":"13","author":"Chen","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e20211314","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1134\/s0006297920120068","article-title":"COVID-19 and oxidative stress","volume":"85","author":"Chernyak","year":"2020","journal-title":"Biochem. (Mosc)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"199075","DOI":"10.1016\/j.virusres.2023.199075","article-title":"Future trajectory of SARS-CoV-2: constant spillover back and forth between humans and animals","volume":"328","author":"Cui","year":"2023","journal-title":"Virus Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"572635","DOI":"10.3389\/fimmu.2020.572635","article-title":"A \"window of therapeutic opportunity\" for anti-cytokine therapy in patients with coronavirus disease 2019","volume":"11","author":"De Stefano","year":"2020","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"116381","DOI":"10.1016\/j.taap.2023.116381","article-title":"Scavenger receptor BI attenuates oxidized phospholipid-induced pulmonary inflammation","volume":"462","author":"Dunigan-Russell","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B18","volume-title":"Frequently asked questions on the emergency use authorization for actemra (tocilizumab) for treatment of COVID-19 [Online]","year":"2022"},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000053156","article-title":"Endocrine and non-endocrine activities of growth hormone secretagogues in humans","volume":"51","author":"Ghigo","year":"1999","journal-title":"Hormone Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","article-title":"Immunopathology of hyperinflammation in COVID-19","volume":"191","author":"Gustine","year":"2021","journal-title":"Am. J. Pathology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"115162","DOI":"10.1016\/j.bcp.2022.115162","article-title":"JAK inhibition as a new treatment strategy for patients with COVID-19","volume":"202","author":"Huang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1096\/fj.201700505R","article-title":"Adiponectin has a pivotal role in the cardioprotective effect of CP\u20103(iv), a selective CD36 azapeptide ligand, after transient coronary artery occlusion in mice","volume":"32","author":"Huynh","year":"2017"},{"key":"B23","doi-asserted-by":"publisher","first-page":"720109","DOI":"10.3389\/fimmu.2021.720109","article-title":"Monocytes and macrophages in COVID-19","volume":"12","author":"Knoll","year":"2021","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.47326\/ocsat.2022.03.57.1.0","article-title":"Evidence-based recommendations on the use of nirmatrelvir\/ritonavir (Paxlovid) for adults in ontario","author":"Komorowski","year":"2022","journal-title":"Infect. Dis. Clin. Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"682871","DOI":"10.3389\/fimmu.2021.682871","article-title":"The role of macrophages in the pathogenesis of SARS-CoV-2-associated acute respiratory distress syndrome","volume":"12","author":"Kosyreva","year":"2021","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1210\/endo.140.9.6948","article-title":"Growth hormone-independent cardioprotective effects of hexarelin in the rat","volume":"140","author":"Locatelli","year":"1999","journal-title":"Endocrinology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.11909\/j.issn.1671-5411.2014.03.007","article-title":"The cardiovascular action of hexarelin","volume":"11","author":"Mao","year":"2014","journal-title":"J. Geriatr. Cardiol."},{"key":"B28","unstructured":"Coronavirus pandemic (COVID-19)\n            MathieuE.\n            RitchieH.\n            Rod\u00e9s-GuiraoL.\n            AppelC.\n            GiattinoC.\n            HasellJ.\n          2020"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12903","DOI":"10.1038\/s41598-019-49472-8","article-title":"Immunometabolic modulation of retinal inflammation by CD36 ligand","volume":"9","author":"Mellal","year":"2019","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e2372","DOI":"10.1002\/rmv.2372","article-title":"The role of cytokines and their antagonists in the treatment of COVID-19 patients","volume":"33","author":"Mohseni Afshar","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virology J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.thromres.2020.04.031","article-title":"The role of Neutrophil Extracellular Traps in Covid-19: only an hypothesis or a potential new field of research?","volume":"191","author":"Mozzini","year":"2020","journal-title":"Thromb. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3389\/fphar.2020.00870","article-title":"Neutrophilia and NETopathy as key pathologic drivers of progressive lung impairment in patients with COVID-19","volume":"11","author":"Narasaraju","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40001-021-00626-3","article-title":"Potential therapeutic options for COVID-19: an update on current evidence","volume":"27","author":"Niknam","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"173854","DOI":"10.1016\/j.ejphar.2021.173854","article-title":"Dexamethasone: therapeutic potential, risks, and future projection during COVID-19 pandemic","volume":"894","author":"Noreen","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.amjms.2021.12.010","article-title":"Endothelial dysfunction in covid-19 infection","volume":"363","author":"Otifi","year":"2022","journal-title":"Am. J. Med. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1038\/emm.2014.38","article-title":"CD36, a scavenger receptor implicated in atherosclerosis","volume":"46","author":"Park","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/biomedicines8080241","article-title":"Synthesis and biomedical potential of azapeptide modulators of the cluster of differentiation 36 receptor (CD36)","volume":"8","author":"Proulx","year":"2020","journal-title":"Biomedicines"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/medsci10040058","article-title":"SARS-CoV-2-Infection (COVID-19): clinical course, viral acute respiratory distress syndrome (ARDS) and cause(s) of death","volume":"10","author":"Ramadori","year":"2022","journal-title":"Med. Sci. (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1001\/jama.2022.9179","article-title":"Dietary supplement sellers receive warnings","volume":"327","author":"Rubin","year":"2022","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.15585\/mmwr.mm7148e2","article-title":"Paxlovid associated with decreased hospitalization rate among adults with COVID-19 - United States, april-september 2022","volume":"71","author":"Shah","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"re3","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci. Signal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"104475","DOI":"10.1016\/j.cellimm.2021.104475","article-title":"CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization","volume":"372","author":"Sun","year":"2022","journal-title":"Cell. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-023-40824-7","article-title":"CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10753-022-01726-w","article-title":"The role of macrophages and alveolar epithelial cells in the development of ARDS","volume":"46","author":"Tao","year":"2023","journal-title":"Inflammation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12931-023-02336-2","article-title":"Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model","volume":"24","author":"Veras","year":"2023","journal-title":"Respir. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.3390\/cells10123495","article-title":"Transcriptomic profiles reveal downregulation of low-density lipoprotein particle receptor pathway activity in patients surviving severe COVID-19","volume":"10","author":"Vlasov","year":"2021","journal-title":"Cells"},{"key":"B53","unstructured":"Coronavirus disease 2019 (COVID-19) situation report-2092020"},{"key":"B54","unstructured":"WHO COVID-19 dashboard2023"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/cells10081897","article-title":"The role of alveolar edema in COVID-19","volume":"10","author":"Yuan","year":"2021","journal-title":"Cells"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1125246","DOI":"10.3389\/fimmu.2023.1125246","article-title":"The development of COVID-19 treatment","volume":"14","author":"Yuan","year":"2023","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.33393\/dti.2021.2347","article-title":"Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury","volume":"15","author":"Zambelli","year":"2021","journal-title":"Drug Target Insights"},{"key":"B58","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/v14020441","article-title":"Na\u00efve human macrophages are refractory to SARS-CoV-2 infection and exhibit a modest inflammatory response early in infection","volume":"14","author":"Zhang","year":"2022","journal-title":"Viruses"},{"key":"B59","doi-asserted-by":"publisher","first-page":"931061","DOI":"10.3389\/fcimb.2022.931061","article-title":"Mechanism of COVID-19 causing ARDS: exploring the possibility of preventing and treating SARS-CoV-2","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1303342\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T04:42:27Z","timestamp":1707280947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1303342\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":59,"alternative-id":["10.3389\/fphar.2024.1303342"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1303342","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"article-number":"1303342"}}